Anterior cruciate ligament injury
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Participants aged between 18 and 50 years old (inclusive), of any gender, with mature skeletal structure and closed epiphyses. (2) Diagnosis of planned ACL tear confirmed through clinical examination and MRI within the past 8-10 weeks; no prior history of ACL injury in the involved or contralateral limb with reconstruction. (3) Stable vital signs and normal liver and kidney function. (4) Body Mass Index (BMI) between 18 and 35. (5) Not participated in any other clinical trials within the past 3 months. (6) Participants fully understand the benefits and risks of the trial, voluntarily agree to participate, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Lower limb conditions such as skin lesions, ulceration, swelling, soft tissue injuries, and vascular damage. (2) Bleeding disorders. (3) Severe primary diseases affecting cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic systems. (4) Patients with abnormal mental behavior who cannot cooperate. (5) Recent use of specific medications such as antiepileptic drugs, immunosuppressants, etc. (6) Inability to undergo preoperative rehabilitation training. (7) Blood pressure >200/110 mm Hg or <90/60 mm Hg. (8) Complete knee joint dislocation or need for repair of structures within the knee joint other than the ACL and meniscus. (9) Other reasons deemed unsuitable by researchers, such as inability to assess efficacy, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score ;HSS score;IKDC ligament score; | — |
Secondary
| Measure | Time frame |
|---|---|
| complications;patient satisfaction;Quadriceps strength, quadriceps morphology, knee flexion angle;Postoperative inflammatory indicators; | — |
Countries
China
Contacts
China-Japan Union Hospital of Jilin University